Literature DB >> 15163012

Immunohistochemical evaluation of hormone receptors in breast cancer: which scoring system is suitable for highly sensitive procedures?

Shinobu Umemura1, Johbu Itoh, Hitoshi Itoh, Akihiko Serizawa, Yuki Saito, Yasuhiro Suzuki, Yutaka Tokuda, Tomoo Tajima, R Yoshiyuki Osamura.   

Abstract

To evaluate hormone receptors immunohistochemically, standardized staining procedures and scoring systems are required. The authors previously reported that highly sensitive procedures affected basic factors for technical validation. The aim of the present study was to show the characteristics of scoring systems for highly sensitive procedures. To examine how highly sensitive procedures enhance the staining intensity and increase the positive cell population, two different staining methods were compared. To evaluate scoring systems, three systems--cell counting score, modified immunoreactive score, and H score--were compared using the same samples stained by an autostaining system. It was found that the highly sensitive procedure increased the positive cell population, especially in breast cancers with a low enzyme immunoassay (EIA) level of less than 100 fmol/mg, and strengthened the staining intensity. This enhancement led to a correlation in a logarithmic curve rather than a linear correlation by all three scoring systems. The results showed that scoring systems including a factor of staining intensity did not have an absolute advantage because boosted staining intensity by highly sensitive procedure did not reflect EIA value or protein contents accurately. To the authors' knowledge, there is no report discussing the nonlinear correlation between biochemical and immunohistochemical assay by highly sensitive procedures; however, it is important to select a scoring system and threshold based on nonlinear correlation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15163012     DOI: 10.1097/00129039-200403000-00002

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  11 in total

1.  Value of staining intensity in the interpretation of immunohistochemistry for tumor markers in colorectal cancer.

Authors:  Inti Zlobec; Luigi Terracciano; Jeremy R Jass; Alessandro Lugli
Journal:  Virchows Arch       Date:  2007-08-03       Impact factor: 4.064

2.  Estrogen Receptor Negative Breast Cancer in India: Do We Really Have Higher Burden of this Subtype?

Authors:  Suraj Manjunath; Jyothi S Prabhu; Rohini Kaluve; Marjorie Correa; T S Sridhar
Journal:  Indian J Surg Oncol       Date:  2011-05-31

3.  Effects of mutant human Ki-ras(G12C) gene dosage on murine lung tumorigenesis and signaling to its downstream effectors.

Authors:  Stephanie T Dance-Barnes; Nancy D Kock; Heather S Floyd; Joseph E Moore; Libyadda J Mosley; Ralph B D'Agostino; Mark J Pettenati; Mark Steven Miller
Journal:  Toxicol Appl Pharmacol       Date:  2008-04-27       Impact factor: 4.219

4.  Immunohistochemistry as an important tool in biomarkers detection and clinical practice.

Authors:  Leandro Luongo de Matos; Damila Cristina Trufelli; Maria Graciela Luongo de Matos; Maria Aparecida da Silva Pinhal
Journal:  Biomark Insights       Date:  2010-02-09

5.  Expression of leptin receptor in endometrial biopsies of endometrial and ovarian cancer patients.

Authors:  Luis Fernando Méndez-López; Martha Imelda Dávila-Rodríguez; Angel Zavala-Pompa; Ernesto Torres-López; Blanca Edelia González-Martínez; Manuel López-Cabanillas-Lomelí
Journal:  Biomed Rep       Date:  2013-05-30

Review 6.  Practical aspects of planning, building, and interpreting tissue microarrays: the Cooperative Prostate Cancer Tissue Resource experience.

Authors:  A Kajdacsy-Balla; J M Geynisman; V Macias; S Setty; N M Nanaji; J J Berman; K Dobbin; J Melamed; X Kong; M Bosland; J Orenstein; J Bayerl; M J Becich; R Dhir; M W Datta
Journal:  J Mol Histol       Date:  2007-02-21       Impact factor: 3.156

7.  A simple and reproducible scoring system for EGFR in colorectal cancer: application to prognosis and prediction of response to preoperative brachytherapy.

Authors:  I Zlobec; T Vuong; S Hayashi; D Haegert; L Tornillo; L Terracciano; A Lugli; J Jass
Journal:  Br J Cancer       Date:  2007-02-20       Impact factor: 7.640

8.  Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer.

Authors:  Elton Rexhepaj; Donal J Brennan; Peter Holloway; Elaine W Kay; Amanda H McCann; Goran Landberg; Michael J Duffy; Karin Jirstrom; William M Gallagher
Journal:  Breast Cancer Res       Date:  2008-10-23       Impact factor: 6.466

9.  Prognostic significance of ESR1 gene amplification, mRNA/protein expression and functional profiles in high-risk early breast cancer: a translational study of the Hellenic Cooperative Oncology Group (HeCOG).

Authors:  George Pentheroudakis; Vassiliki Kotoula; Anastasia G Eleftheraki; Eleftheria Tsolaki; Ralph M Wirtz; Konstantine T Kalogeras; Anna Batistatou; Mattheos Bobos; Meletios A Dimopoulos; Eleni Timotheadou; Helen Gogas; Christos Christodoulou; Kyriaki Papadopoulou; Ioannis Efstratiou; Chrisoula D Scopa; Irene Papaspyrou; Dimitrios Vlachodimitropoulos; Helena Linardou; Epaminontas Samantas; Dimitrios Pectasides; Nicholas Pavlidis; George Fountzilas
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

10.  Reliable quantification of protein expression and cellular localization in histological sections.

Authors:  Michaela Schlederer; Kristina M Mueller; Johannes Haybaeck; Susanne Heider; Nicole Huttary; Margit Rosner; Markus Hengstschläger; Richard Moriggl; Helmut Dolznig; Lukas Kenner
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.